Is G1 Therapeutics Inc (GTHX) Stock at the Top of the Biotechnology Industry?

G1 Therapeutics Inc (GTHX) is around the top of the Biotechnology industry according to InvestorsObserver. GTHX received an overall rating of 73, which means that it scores higher than 73 percent of all stocks. G1 Therapeutics Inc also achieved a score of 88 in the Biotechnology industry, putting it above 88 percent of Biotechnology stocks. Biotechnology is ranked 20 out of the 148 industries.

GTHX has an Overall Score of 73. Find out what this means to you and get the rest of the rankings on GTHX!

See Full GTHX Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 73 means the stock is more attractive than 73 percent of stocks. These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With G1 Therapeutics Inc Stock Today?

G1 Therapeutics Inc (GTHX) stock is trading at $4.54 as of 2:18 PM on Wednesday, Mar 27, a gain of $0.25, or 5.83% from the previous closing price of $4.29. The stock has traded between $4.28 and $4.76 so far today. Volume today is 1,248,071 compared to average volume of 1,222,679. Click Here to get the full Stock Report for G1 Therapeutics Inc stock.